NEW YORK (GenomeWeb News) – Researchers at Albert Einstein College of Medicine will use two CLC Bio software platforms in its epigenomics and other research programs under a new site license agreement, the Danish company said today.

CLC Bio said that the College's Einstein Center for Epigenomics will use its Genomics Workbench and its Genomics Server to handle data it generates in its high-throughput sequencing programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.